CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,197,943 | +21.4% | 957,951 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $5,104,453 | +78.2% | 824,629 | +10.9% | 0.00% | – |
| Q1 2023 | $2,864,043 | +193.2% | 743,907 | +136.1% | 0.00% | – |
| Q4 2022 | $976,919 | +1358.1% | 315,135 | +1810.6% | 0.00% | – |
| Q3 2022 | $67,000 | -65.8% | 16,494 | -59.0% | 0.00% | – |
| Q2 2022 | $196,000 | +1.0% | 40,264 | +86.3% | 0.00% | – |
| Q1 2022 | $194,000 | +22.8% | 21,612 | +53.4% | 0.00% | – |
| Q4 2021 | $158,000 | +23.4% | 14,085 | +84.6% | 0.00% | – |
| Q3 2021 | $128,000 | – | 7,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 17,923,892 | $299,329,000 | 65.12% |
| Vida Ventures Advisors, LLC | 3,931,818 | $65,661,000 | 18.81% |
| Samsara BioCapital, LLC | 1,537,533 | $25,677,000 | 4.03% |
| VR Adviser, LLC | 1,127,272 | $18,825,000 | 2.42% |
| Logos Global Management LP | 1,069,545 | $17,861,000 | 1.29% |
| Cormorant Asset Management, LP | 1,727,273 | $28,724,000 | 1.17% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $161,686,000 | 0.95% |
| Affinity Asset Advisors, LLC | 203,183 | $3,393,000 | 0.86% |
| RA Capital Management | 3,577,094 | $59,737,000 | 0.83% |
| Boxer Capital, LLC | 1,334,227 | $22,282,000 | 0.78% |